Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 16.64B 2.47B 2.14B 2B 1.83B 3.44B 235B 3.49B 23.57B 9.21B 118B 9.27B 9.07B 393B P/E 2026 *
32x
P/E 2027 * -161x
Enterprise Value 16.64B 2.47B 2.14B 2B 1.83B 3.44B 235B 3.49B 23.57B 9.21B 118B 9.27B 9.07B 393B EV / Sales 2026 *
15.4x
EV / Sales 2027 * 13.2x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day+0.08%
1 week+2.46%
Current month+5.13%
1 month-6.64%
3 months-11.60%
6 months+10.45%
Current year+10.61%
1 week 35.83
Extreme 35.83
39.26
1 month 33.41
Extreme 33.41
43.5
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
76.88
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.577775
81.48
Manager TitleAgeSince
Chief Executive Officer 52 10/11/2015
Director of Finance/CFO 60 10/11/2015
Investor Relations Contact 38 30/12/2020
Director TitleAgeSince
Chairman 52 10/11/2015
Director/Board Member 58 10/11/2015
Chairman 50 10/11/2015
Date Insider Type Main position Quantity % Market Cap.
05/01/26 Buy

Director

4,200 0.0010%
24/11/25 Buy

Director

7,000 0.0017%
01/09/23 Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
+0.08%+2.46%-43.95%+82.99% 2.47B
-0.30%-0.67%+18.18%+70.85% 48.9B
+1.31%+1.93%+55.04%+124.00% 40.42B
-2.68%+5.82%+18.60%+82.73% 12.6B
-0.29%-1.27%-6.58%+18.02% 12.39B
-0.19%-0.76%+30.40%+135.91% 9.07B
-0.08%+7.60%+24.69%+40.11% 7.53B
+0.29%+3.61%+39.38%-12.72% 7.13B
+0.29%+1.00%+12.98%+187.43% 6.78B
-0.87%+2.74%-25.38%+28.51% 5.83B
Average -0.27%+3.44%+12.34%+75.78% 15.31B
Weighted average by Cap. -0.04%+3.43%+25.08%+83.78%

Financials

2026 *2027 *
Net sales 1.08B 160M 139M 130M 119M 223M 15.27B 226M 1.53B 598M 7.65B 601M 588M 25.5B 1.26B 187M 162M 151M 138M 260M 17.79B 264M 1.78B 696M 8.91B 700M 685M 29.71B
Net income 526M 78M 67.58M 63.32M 57.75M 109M 7.44B 110M 745M 291M 3.73B 293M 286M 12.42B -102M -15.13M -13.1M -12.28M -11.2M -21.05M -1.44B -21.38M -144M -56.45M -722M -56.79M -55.55M -2.41B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
12/08/26 CN¥37.11 +0.08% 10,038,222
11/08/26 CN¥37.08 -0.59% 11,306,644
10/08/26 CN¥37.30 -1.82% 15,164,694
07/08/26 CN¥37.99 +4.20% 16,250,319
06/08/26 CN¥36.46 +0.66% 12,081,814

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock